Dr. Woodrow Webster McWilliams III, MD

Dr. McWilliams practices at Piedmont Columbus Regional - Midtown in Columbus, Georgia, part of Piedmont Healthcare.

Dr. McWilliams' NPI, 1568794030, was assigned on February 8, 2010. Dr. McWilliams graduated from Morehouse School Of Medicine in 2001. Dr. McWilliams holds Georgia license 055864.

Dr. McWilliams' primary practice is Piedmont Columbus Regional - Midtown, at 710 Center Street, Columbus, GA 31901 in Muscogee County. The practice phone is (706) 571-1000.

Dr. McWilliams' primary practice is Piedmont Columbus Regional - Midtown in Columbus, Georgia, part of Piedmont Healthcare. Dr. McWilliams is also affiliated with St. Francis - Emory Healthcare. The medical group on file is Radiation Oncology of Columbus. Dmand AI also links Dr. McWilliams to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McWilliams practices, 5 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. McWilliams' primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. McWilliams is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. McWilliams' licenses on file in 2 states: Georgia and Pennsylvania.

Dmand AI lists anal cancer radiation, bladder cancer radiation, bone cancer radiation, brain cancer radiation, brain tumor radiation, breast cancer radiation, cancer radiation-upper GI and colorectal cancer radiation among the conditions Dr. McWilliams treats.

CMS data shows 2,493 Medicare services from Dr. McWilliams across 16 procedure codes in 2024, for 264 Medicare patients. Medicare paid $144,367 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 264 Medicare patients who saw Dr. McWilliams in 2024. The largest group is 65 to 74, with 160 patients. 75% of them have cancer, and 75% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McWilliams' median patient age at 71, with 22% women.

In 2024, Dr. McWilliams wrote 212 Medicare Part D claims for 73 patients. 52% of them were for generic drugs. CMS names the drug for 151 of them, across 3 drugs with 11 or more claims each, at $236,084 in total drug cost. In 2023, CMS named 35 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. McWilliams for performance year 2024, reported as part of a group. Dr. McWilliams accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. McWilliams. Dr. McWilliams' most frequent co-author is Mark G. Trombetta, MD.

CMS Open Payments shows 89 general payments to Dr. McWilliams from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Sumitomo Pharma America, Inc. paid the most, $235.

Dr. McWilliams graduated from Morehouse School Of Medicine in 2001.

Dr. McWilliams is in network with 8 carriers, including Aetna, United Healthcare and Cigna. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.